WMSA
AXSM icon

Weiss Multi-Strategy Advisers’s Axsome Therapeutics AXSM Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,000
Closed -$290K – 657
2022
Q1 		$290K Sell
7,000
-7,139
-50% -$221K 0.01% 607
2021
Q4 		$534K Sell
14,139
-3,127
-18% -$115K 0.01% 545
2021
Q3 		$569K Buy
17,266
+4,251
+33% +$166K 0.01% 541
2021
Q2 		$878K Buy
13,015
+465
+4% +$27.9K 0.02% 504
2021
Q1 		$711K Sell
12,550
-513
-4% -$36.1K 0.02% 521
2020
Q4 		$1.06M Buy
13,063
+3,063
+31% +$229K 0.02% 482
2020
Q3 		$713K Buy
10,000
+5,000
+100% +$390K 0.02% 453
2020
Q2 		$411K Buy
+5,000
New +$385K 0.01% 479

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $186M AUM 51.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return